South Africa is set to reportedly sell the one million doses of the AstraZeneca COVID-19 vaccine that it had earlier purchased from India.
According to Health Minister Zweli Mkhize, it is planning to sell the vaccine to it’s sister countries in the African Union.
Moreover, the old vaccines were substituted by the new ones previously delivered by Serum Institute of India.
This was upon discovering that the effectiveness of the vaccine they proffered was limited against the outbreak of new coronavirus variant in South Africa.
Last month, the Serum Institute of India delivered around a million doses of the AstraZeneca vaccine to South Africa.
However, this month, an additional 5,00,000 was supposedly due to be delivered for being used in the first phase of rolling it out to health care and other priority workers.
Post reports of the vaccine indicating limited efficiency against the new strain of the virus, South Africa decided against starting the first phase of its vaccine rollout.
Declining reports that the vaccines would be donated or sold at half price, Mkhize said that there will be no wasteful expenditure.
He further added that inquiries came from no less than 25 countries who actually wanted access to those doses of the vaccine.
With the emergence of second wave of the virus in South Africa followed by strictlockdown regulations in December 2020, the vaccination campaign took off.
It is to be believed that an estimated 1,210 new COVID-19 cases and 219 deaths were reported overnight despite a gradual decline in infections and deaths.
Check all the recent news updates and share market updates